Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UROKINASE: 55 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
55
Total FAERS Reports
8 (14.5%)
Deaths Reported
27
Hospitalizations
55
As Primary/Secondary Suspect
8
Life-Threatening
1
Disabilities
Discontinued
Status

FDA Application: 021846 ·

First Report: 20130204 · Latest Report: 20240409

What Are the Most Common UROKINASE Side Effects?

#1 Most Reported
Drug ineffective
15 reports (27.3%)
#2 Most Reported
Haemorrhagic transformation stroke
5 reports (9.1%)
#3 Most Reported
Gastrointestinal haemorrhage
4 reports (7.3%)

All UROKINASE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 15 27.3% 1 9
Haemorrhagic transformation stroke 5 9.1% 1 0

Who Reports UROKINASE Side Effects? Age & Gender Data

Gender: 25.5% female, 74.5% male. Average age: 44.7 years. Most reports from: CN. View detailed demographics →

Is UROKINASE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2013 3 0 2
2014 2 0 2
2015 2 1 0
2016 2 0 2
2017 2 0 2
2018 2 2 0
2020 1 0 1
2022 2 0 0
2024 2 0 2

View full timeline →

What Is UROKINASE Used For?

IndicationReports
Ischaemic stroke 6
Product used for unknown indication 5

Official FDA Label for UROKINASE

Official prescribing information from the FDA-approved drug label.